Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

600329.SS ✓ COMPLIANT ☆ Track — members

SSE · Healthcare · Pharmaceuticals ·

China Mid Cap Analyst: N/A

Last Close

$5.37

▼ -1.69%

Market Cap $3.59B · Vol 3.77M

Key Metrics

P/E Ratio

12.80

FWD: 22.24

Market Cap

$3.59B

Mid Cap

Div Yield

13.24%

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

42.46

Momentum

Beta

1.41

vs Market

52W High

$7.56

25.05% below

52W Low

$5.15

5.05% above

Volume

3.77M

Avg 4.41M

P/B

4.90

Price-to-book

ROE

28.38%

Return on equity

Free Float

42.84%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (600329.SS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does 600329.SS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.72%

-8.17%

-17.02%

-16.25%

YTD

-20.71%

-19.17%

+4.89%

+22.36%

Financials & Valuation

TTM · Annual

Total Revenue	$703.17M
Net Income	$301.83M
Revenue Growth (YoY)	-7.39%
Gross Margin	73.31%
Operating Margin	18.87%
Net Profit Margin	42.92%
ROE	28.38%
ROA · ROIC	22.15% · 27.84%

P/E Ratio	12.80
Forward P/E (FY1)	22.24
PEG Ratio	-3.97
P/S	7.14
P/B	4.90
P/FCF	102.49
EPS Growth	N/A
Outstanding Shares	770.09M

Technical Indicators

50-Day SMA	$5.63
200-Day SMA	$6.29
RSI (14)	42.46
Beta	1.41
52-Week High	$7.56
52-Week Low	$5.15

Volume Today	3.77M
Avg Daily Volume (30D)	4.41M
Relative Volume	0.85x
Volatility (10D)	12.50
Volatility (30D)	35.04
Free Float	42.84%

Analyst Consensus

N/A

Current Price $5.37

Mean Target N/A

52W Low$5.15 52W High$7.56

Current

Target

$5.15 $7.56

Current Analyst target

· 0 analysts

Identifiers

ExchangeSSE

FIGIBBG001SHZS90

ISINCNE000001808

CountryChina

Sub-IndustryAlternative Medicine

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

000538.SZ Yunnan Baiyao Group Co Ltd -0.85% 600085.SS Beijing Tong Ren Tang Co Ltd -1.45% 000423.SZ Dong-E-E-Jiao Co Ltd -1.44% 002603.SZ Shijiazhuang Yiling Pharmaceutical Co Ltd -0.82% 600535.SS Tasly Pharmaceutical Group Co Ltd -0.65%

Company Profile

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a China-based company principally engaged in the research, development, manufacturing and retail of Chinese herbal medicines, Chinese patent medicines, chemical raw materials and preparations, and nutritional health products. The Company operates its businesses through three segments. The Chinese Patent Medicine segment is mainly engaged in the research, development, manufacturing and sales of Chinese medicines, including Su Xiao Jiu Xin Pill, Jing Wan Hong Ruan Gao, An Gong Niu Huang Pill, Qing Gong Shou Tao Pill and other products. The Western Medicine segment is mainly engaged in the research, development, manufacturing and sales of Western medicines. The Others segment mainly includes economic information consulting services, house leasing and other businesses. The Company mainly operates its businesses in the domestic and overseas markets.